Key Takeaways

• A senior NHS official allegedly threatened staff regarding criticism of the federated data platform (FDP) provided by Palantir.
• Concerns have been raised about the transparency and security of the platform, particularly regarding data access by Palantir engineers.
• Debate over the FDP is scheduled in Parliament as scrutiny of NHS technology contracts increases.

Concerns Over Federated Data Platform and Staff Intimidation

Reports have surfaced that a senior NHS official threatened staff members against voicing criticism of the federated data platform (FDP) after its rollout. This platform, developed by US data analytics firm Palantir under a £330 million contract, has faced backlash from clinicians and rights groups due to the company’s ties with government surveillance, including the U.S. Immigration and Customs Enforcement.

According to the Financial Times, an anonymous NHS analytics official who questioned the necessity of the platform received a warning call from a senior colleague, threatening job security if criticism continued. The employee noted that they are not alone in receiving such warnings; other NHS staff have also been discouraged from raising concerns publicly.

Dr. Marc Farr, chair of the Chief Data and Analytical Officer Network (CDAON), expressed concern over reports of bullying related to the FDP and emphasized the importance of providing a supporting environment where staff can voice their concerns. He noted the CDAON’s role as a “critical friend” to NHS England regarding the platform, underlining the need for an open dialogue about any aspect of the technology.

In response to the allegations, a spokesperson for NHS England stated that the organization takes complaints seriously and encourages staff to come forward with concerns. They highlighted the FDP’s intended benefits, such as improved patient care, faster cancer diagnoses, and cost savings for NHS organizations.

Duncan McCann, a technology and data lead at the Good Law Project, remarked on the dangers of silencing NHS staff who voice concerns about patient risks, asserting that intimidation could ultimately lead to the failure of implementation of such technologies. Dr. Devan Moodley, former NHS doctor and current CEO at Health Connect Global, echoed these sentiments, stressing that honest feedback from all stakeholders is essential for innovation in health technology. He warned that silencing voices results in compliance rather than genuine adoption, which can compromise patient care.

Concerns have also been raised about the access granted to Palantir engineers working on the FDP, as they were issued NHS email accounts, potentially allowing access to sensitive staff information. Palantir defended this practice as standard for government suppliers, asserting that utilizing government systems is more secure.

As the controversy unfolds, UK MPs are scheduled to debate the FDP in Parliament on April 16, with a review of NHS England’s contract with Palantir set for early 2027. There are indications that government officials are considering activating a break clause in the contract amid growing scrutiny of NHS technology partnerships.

The content above is a summary. For more details, see the source article.